Use of TDCS Stimulation in Neurological and Gynaecological Conditions (tDCS)

March 17, 2025 updated by: Poznan University of Physical Education
The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.

Study Overview

Detailed Description

Neurological patients:

  1. Main objective: The aim of the study is to see whether the use of tDCS stimulation incorporated into a rehabilitation programme in post-stroke patients and patients with spinal cord and nerve root dysfunction following neurosurgery and non-surgery will improve upper and lower limb function.
  2. Specific aim: To test whether the application of 1, 5 or 10 tDCS stimulations is sufficient to achieve improvements in upper and lower limb function, taking into account the dominant limb.
  3. Description of the study group

    The study will include women and men after stroke and spinal cord and nerve root dysfunction admitted for rehabilitation after surgery and not qualified for surgery, as well as healthy subjects. Study participants will be aged between 20-90 years. Post-stroke subjects with spinal cord and nerve root dysfunction will undergo individual rehabilitation using the PNF (Proprioceptive Neuromuscular Facilitation, Polish for proprioceptive neuromuscular facilitation) neurophysiological method performing upper and lower limb patterns. Rehabilitation will last between one and three months. Inclusion criterion: impairments of upper and lower limb function. Exclusion criterion: no written consent to participate in the study. Due to the assessment to be carried out, participants will be divided into groups:

    • women and men after stroke with and without tDCS stimulation 1, 5 or 10 treatments,
    • women and men with spinal cord and nerve root disorders after surgery with and without tDCS stimulation 1, 5 or 10 treatments,
    • women and men with spinal cord and nerve root disorders not qualified for surgery with tDCS stimulation 1.5 or 10 treatments and without,
    • healthy women and men undergoing all procedures including tDCS stimulation 1.5 or 10 without rehabilitation,
    • women and healthy men undergoing all procedures without tDCS stimulation and rehabilitation.
  4. Methods used in the research:

For the purpose of the study to be conducted, the subjects will have an assessment of:

  • body weight, body height, body composition using the Tanita BC-418 MA device before the start of the study, the subject stands barefoot on the electrodes in the shape of the foot, in his/her hand he/she also grasps the electrodes while being only in underwear and a measurement is taken, body composition indicators like BMI (Body Mass Index), muscle mass, fat mass, lean body mass and water content will be assessed, measured before the start of the study
  • biomechanical and viscoelastic properties of the skin using the MyotonPRO: during the measurement the subject will be in a standing position, the limbs of the subject will be exposed, the skin of both upper limbs (arm and forearm) and lower limbs (thigh and shank) will be assessed, on the anterior, posterior, lateral and medial sides, measurement before and after the test,
  • postural stability using the stabilometric platform Coordination, the subject will stand on the platform barefoot only in underwear, upper limbs placed along the torso, measurement will be done with eyes open and closed for a period of 30 seconds, measurement before and after the test,
  • upper limb reaction time using the Witty SEM Microgate, taking into account the dominant and non-dominant upper limb, the test person will stand in front of special sensors (semaphores) which will display letters and numbers in different colours, when ready the test person will have to find the small green letter 'a' 20 times as fast as possible. The total time of the test will be counted, the test person will be advised to be in comfortable sportswear (not restricting the movement of the upper limbs), the dominant and non-dominant limbs will be evaluated separately, measuring before and after the test,
  • assessment of the squeezing force of the right and left limb (hand dynamometer), test subjects will be asked to grasp the dynamometer and squeeze their hand with maximum force within 5 seconds.
  • lower limb reaction time using the Balance Toutor MedTouch platform, the test person will be in comfortable clothing, will be attached by a special harness to the device's extension arm to avoid a possible fall during the test, the test time for one person will last five minutes, the test person will walk on the device's treadmill at a speed of 3 m/s for two minutes, in order to adapt to the walking pace, in front of him/her on a monitor the test subject will see an image of the path in the forest on which he/she is walking in order to divert his/her attention, the device will then elicit a simulated fall reaction in forward, backward and sideways taking into account the test for the dominant and non-dominant lower limb, at the end of the test a record will be obtained for each test subject, recorded by the device in reaction time values, the test will be performed before and after the test,
  • tDCS Sooma DUO stimulation, the subject will be subjected to neuromodulation of the motor cortex, the treatment will be carried out in the sitting position, the subject will wear a cap with electrodes attached to the head, the treatment time will be 20-30 minutes, the maximum direct current will be 2 mA, the number of treatments will be 1, 5 or 10 (5 or 10 treatments daily from Monday to Friday) in the afternoon. Before and after the neuromodulation, tests will be carried out for the dominant and non-dominant hand: tapping on a tablet for 30 seconds, reflex flop test on a tablet (there will be glowing points that the subject must touch, the shorter the time to touch all the points, the better the score) and nine-hole peg test. In the course of neurostimulation, after 10 minutes the test person will perform mirror therapy, i.e. The subject will then perform mirror therapy, i.e. movements of the dominant hand controlled in the mirror image (wrist extension - 1 minute and 30 seconds pause, wrist flexion - 1 minute and 30 seconds pause, finger flexion and extension - 1 minute and 30 seconds pause, fist clenching and opening - 1 minute and 30 seconds pause, finger inversion and adduction - 1 minute and 30 seconds pause, middle finger tapping - 1 minute and 30 seconds pause, all fingers tapping - 1 minute).

Completion of questionnaires, the questionnaires used are:

  • Roland-Morris disability questionnaire, the questionnaire is completed by the examiner before and after examinations in patients with spinal cord and nerve root disorders,
  • Barthel scale, a questionnaire to be filled in by the examiner before and after examinations in stroke patients,
  • ASIA scale classification of spinal cord injuries, questionnaire to be filled in by the examiner before and after examinations in patients with spinal cord and nerve root disorders
  • Oswestry questionnaire assessment of lumbar spine pain intensity in various activities, questionnaire to be completed by the subject before and after the study,
  • Neck Disability Index questionnaire for cervical spine pain before and after the study,
  • Sexual Satisfaction Scale for Women (SSS - W - R15), assessment of satisfaction with current sexual life as well as communication with partner and sexual adjustment, questionnaire to be completed by the subject before and after the study,
  • male sex life evaluation questionnaire IIEF-5 is filled in by the subject before and after the study,
  • Katz scale is filled in by the subject before and after the study,
  • Lawton scale is filled in by the subject before and after the study,
  • WHOQOL BREF quality of life questionnaire to be completed by the subject before and after the study.

Planned procedures:

  1. recruitment of study participants,
  2. completion of questionnaires and scales,
  3. assessment of weight, height and body composition,
  4. ocean biomechanical and viscoelastic properties of the skin using MyotonPRO,
  5. assessment of postural stability using the stabilometric platform Coordination,
  6. upper limb reaction time using the Witty Sem Macro Gait device taking into account the dominant and non-dominant limb,
  7. middle finger tapping test,
  8. squeeze strength assessment,
  9. lower limb reaction time using the Balance Toutor MedTouch platform,
  10. tDCS stimulation.

Gynaecology patients:

  1. The aim of the study is to test the effect on pain reduction in women with gynaecological conditions such as endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome, who have had no treatment other than tDCS stimulation.
  2. Specific objective: application of stimulation in quantities; 3 treatments, 5 treatments and 10 treatments.
  3. Inclusion criterion: women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) not using any treatment other than tDCS stimulation.

Exclusion criterion: use of treatment other than tDCS stimulation, no written consent to participate in the study.

Patients who do not consent to tDCS stimulation will be placed in the control group.

Gynaecological patients will be asked to complete anonymously standardised questionnaires before and after stimulation, i.e. after 3 or 5 or 10.

Age of female respondents 18-70

For the purpose of the study to be conducted, the subjects will have an assessment of:

body weight, body height, body composition using the Tanita BC-418 MA device before the start of the study, the subject stands barefoot on the electrodes in the shape of the foot, in his/her hand he/she also grasps the electrodes while being only in underwear and a measurement is taken, body composition indicators like BMI (Body Mass Index), muscle mass, fat mass, lean body mass and water content will be assessed, measured before the start of the study biomechanical and viscoelastic properties of the skin using the MyotonPRO: during the measurement the subject will be in a standing position, the limbs of the subject will be exposed, the skin of both upper limbs (arm and forearm) and lower limbs (thigh and shank) will be assessed, on the anterior, posterior, lateral and medial sides, measurement before and after the test,

Standardised questionnaires:

  1. quality of life questionnaire WHOQOL-BREF.
  2. women's sexual satisfaction scale SSS-W-15 and Female Sexual Function Index
  3. Oswestry questionnaire
  4. Insomnia Severity Index.

Planned procedures:

  1. recruitment of study participants,
  2. completion of questionnaires and scales,
  3. assessment of weight, height and body composition,
  4. assessment of postural stability using the stabilometric platform Coordination,
  5. tDCS stimulation. Postural stability using the stabilometric platform Koordynacja, the subject will stand on the platform barefoot in underwear only, upper limbs placed along the torso, measurement will be taken with eyes open and closed for a period of 30 seconds, pre- and post-test measurement, In gynaecological patients of each stimulation is 20 minutes, current intensity to individual patient feeling, not exceeding 2 mA. Stimulation will be performed in a seated position.

Planned use of research results It is planned to present the obtained results in the form of publications in punctuated scientific journals and at Polish and foreign scientific conferences/congresses/symposia. Upon completion of the research experiment, the research participants will receive the results of the research along with their interpretation.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Poznan, Poland, 61-871
        • Recruiting
        • 1Department of Physiotherapy, Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wlkp., 61-871 Poznan
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Neurological patients

Inclusion Criteria:

  • impairment of upper and lower limb function.

Exclusion Criteria:

  • no written consent to participate in the study.

Gynaecological patients

Inclusion Criteria:

  • women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) with no treatment other than tDCS stimulation.

Exclusion Criteria:

  • no written consent to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: tDCS stimulation
The study group will have tDCS stimulation.
tDCA stimulation not exceeding 2 mA
Other Names:
  • tDCS stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body height using Tanita BC-418 MA device
Time Frame: through study completion, an average of 1 year
height will be measured in centimeters
through study completion, an average of 1 year
biomechanical and viscoelastic properties of the skin using MyotonPRO
Time Frame: through study completion, an average of 1 year
The tissue voltage will be measured in Hertz (Hz)
through study completion, an average of 1 year
postural stability using the stabilometric platform Koordynacja
Time Frame: through study completion, an average of 1 year
the lower the frequency of anterior-posterior and medial-lateral swings, the better the stability
through study completion, an average of 1 year
upper limb reaction time using the Witty SEM Microgate device
Time Frame: through study completion, an average of 1 year
the shorter the time in seconds measured with a stopwatch, the better the result,
through study completion, an average of 1 year
assessment of right and left limb compression strength (hand dynamometer)
Time Frame: through study completion, an average of 1 year
test participants will be asked to grasp the dynamometer and clench their hands at maximum force for 5 seconds, the higher the value measured in kilograms, the greater the hand strength
through study completion, an average of 1 year
lower limb reaction time using the Balance Toutor MedTouch platform
Time Frame: through study completion, an average of 1 year
the shorter the time expressed in seconds, the better the function of the upper limb
through study completion, an average of 1 year
tDCS stimulation
Time Frame: through study completion, an average of 1 year
the subject will be subjected to neuromodulation of the motor cortex, the treatment will be carried out in sitting position, the subject will have a cap on his head with electrodes attached, the treatment time will be 20-30 minutes, the maximum value of direct current will be 2 mA, the number of treatments will be 1, 3, 5 or 10 ( 5 or 10 treatments performed daily from Monday to Friday) in the afternoon
through study completion, an average of 1 year
tapping test, reflex Flop test, Nine-Hole-Peg Test
Time Frame: through study completion, an average of 1 year
before and after the neuromodulation, the shorter the time expressed in seconds, the better the hand performance
through study completion, an average of 1 year
questionnaire Rolland-Morris
Time Frame: through study completion, an average of 1 year
maximum number of points 24, the higher the point value the higher the disability
through study completion, an average of 1 year
Barthel scale
Time Frame: through study completion, an average of 1 year
maximum score 100, the higher the score the more independent the person is
through study completion, an average of 1 year
ASIS scale
Time Frame: through study completion, an average of 1 year
maximum score 5, the higher the score the better the function
through study completion, an average of 1 year
Oswestry questionnaire
Time Frame: through study completion, an average of 1 year
maximum score 50, the higher the score the greater the disability due to lumbosacral pain
through study completion, an average of 1 year
Neck Disability Index questionnaire
Time Frame: through study completion, an average of 1 year
maximum score 50, the higher the score the greater the disability due to cervical pain
through study completion, an average of 1 year
Sexual Satisfaction Scale for Women questionnaire
Time Frame: through study completion, an average of 1 year
Maximum score 55, the lower the score the lower the sexual satisfaction
through study completion, an average of 1 year
Female Sexual Function Index questionnaire
Time Frame: through study completion, an average of 1 year
Maximum score 36, the lower the score the lower the sexual satisfaction
through study completion, an average of 1 year
IEF-5 male sex life assessment questionnaire
Time Frame: through study completion, an average of 1 year
A score of 21 or less may indicate symptoms of penile erectile dysfunction
through study completion, an average of 1 year
Katz scale (ADL - Activities of Daily Living)
Time Frame: through study completion, an average of 1 year
maximum score of 6 indicates preserved activities of daily living, lower scores indicate loss of function
through study completion, an average of 1 year
Lawton scale - IADL (basic activities of daily living)
Time Frame: through study completion, an average of 1 year
The maximum number of points is 27, the lower the score indicates a reduction in everyday functions
through study completion, an average of 1 year
WHOQOL-BREF questionnaire
Time Frame: through study completion, an average of 1 year
130 points (this is the maximum number of points that can be obtained) if it is satisfactory quality of life, 26 points (this is the minimum number of points that can be obtained) if there is no satisfactory quality of life
through study completion, an average of 1 year
Insomnia Severity Index
Time Frame: through study completion, an average of 1 year
maximum score of 28 indicating severity of insomnia symptoms, the lower the score the lower the insomnia symptoms
through study completion, an average of 1 year
body weight using Tanita BC-418 MA device
Time Frame: through study completion, an average of 1 year
body weight will be measured in kilograms
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

February 5, 2025

First Submitted That Met QC Criteria

March 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 17, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

When contacted by e-mail, when submitting a publication to a journal, editors often wish to send the raw data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on tDSC stimulation

Subscribe